Document:

Exhibit
10.1

 

EMPLOYMENT
SEPARATION AGREEMENT

 

This
Employment Separation Agreement (the “Agreement”) is made and entered into by and between James B. Boyd (“Executive”)
and Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”), effective as of September, 21 2020
(the “Effective Date”).

 

W
I T N E S S E T H:

 

WHEREAS,
Executive is the President and Chief Financial Officer of the Company; and

 

WHEREAS,
Executive is party to an employment offer letter agreement with the Company, dated August 14, 2017 (the “Offer Letter”),
an Employee Confidential Information and Assignment of Inventions Agreement with the Company, attached as Exhibit A (including
exhibits thereto, and a Change in Control Agreement with the Company, effective as of June 17, 2016 (the “Change in Control
Agreement” and, together with the Offer Letter and the Inventions and Restrictive Covenant Agreement, the “Employment
Agreements”);

 

WHEREAS,
the Company and the Executive have agreed to the termination of Executive’s employment with the Company in accordance with
this Agreement; and

 

WHEREAS,
the Company and Executive wish to set forth herein certain agreements and understandings in this Agreement relating to Executive’s
termination of employment;

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein contained, and for other good and valuable consideration,
the legal sufficiency of which is hereby acknowledged, the Company and Executive agree as follows:

 

1.
Employment Separation.

 

(a) Termination
of Employment; Resignation as Officer. Executive’s employment with the Company will terminate, and Executive shall
be deemed to have resigned from service as President and Chief Financial Officer of the Company (and any other positions held
with the Company or any affiliates), effective (i) at 11:59 P.M. Pacific Time on the day before the day another individual
commences service as Chief Financial Officer of the Company, or, if the Chief Executive Officer of the Company (the
“CEO”) desires that Executive remain employed to provide transition services following such date, such
later date as may be agreed to by Executive and the CEO or (ii) on such earlier date as the CEO determines (the
“Termination Date”), subject to the Company’s continued right to terminate the Executive’s
employment due to Executive’s Disability (as defined in the Change in Control Agreement) or for “Cause” (as
defined in the Change in Control Agreement). Executive and the Company are separately entering to a consulting agreement
substantially in the form attached hereto as Exhibit D (the “Consulting Agreement”) relating to
Executive’s provision of certain consulting services following the Termination Date.

 

(b)
Payment of Accrued Amounts. In connection with Executive’s termination of employment, Executive will receive (a)
any unpaid salary earned through the Termination Date and any unused vacation accrued through the Termination Date (payable on
the Termination Date) and (b) reimbursement for any unreimbursed business expenses properly incurred by Executive through the
Termination Date, in accordance with the Company’s expense reimbursement policy (the “Accrued Amounts”).

 

    	1 

    	 

    

(c)
No Further Employee Compensation and Benefits. Other than the payments and benefits specifically set forth in this Agreement,
the Executive agrees that the Company and its subsidiaries and controlled affiliates do not owe Executive any additional payments,
compensation, remuneration, bonuses, incentive compensation (cash or equity-based, including, without limitation, options, restricted
stock and restricted stock units), benefits, warrants, severance, reimbursement of expenses or commissions of any kind whatsoever,
or other similar compensation, including any obligations under the Offer Letter or the Change in Control Agreement, and except
as provided in this Agreement, Executive is not entitled to any further compensation or eligibility for participation in any benefit
plans, agreements, or arrangements maintained or contributed to by the Company or its subsidiaries and other affiliates, if any,
after the Termination Date; provided, however, that the foregoing shall not extend to (a) any vested benefits under
the Company’s 401(k) retirement plan, if any, and the right to elect continuation coverage under the Consolidated Omnibus
Budget Reconciliation Act (“COBRA”), (b) Executive’s rights, if any, to indemnification or advancement
of expenses in accordance with the Company’s certificate of incorporation, bylaws or other corporate governance document,
or any applicable insurance policy or applicable law or any indemnification agreement with Executive, or (c) Executive’s
rights and entitlements with respect to outstanding equity awards, which shall remain subject to the terms and conditions of the
applicable award agreements and plan(s) pursuant to which such awards were granted, as may be amended from time to time, including
by this Agreement.

 

(d)
No Representation as Company Officer. With the exception of the duties and responsibilities set forth in this Agreement,
Executive acknowledges and agrees that he is relieved of all duties and responsibilities for the Company and its subsidiaries
and other affiliates as of the Termination Date, that after the Termination Date, Executive will not have the authority to bind
the Company or any of its subsidiaries or other affiliates, and that after the Termination Date, Executive will not contact the
Company’s stockholders or any past, current, or prospective customers, distributors, manufacturers, partners or suppliers
of the Company or any of its subsidiaries, affiliates or licensees on behalf of the Company or any of its subsidiaries or other
affiliates. Effective as of 11:59 P.M. Pacific Time on the Termination Date, Executive shall cease and be deemed to have resigned
from any and all titles, positions and appointments the Executive holds with any of the Company’s subsidiaries or controlled
affiliates, whether as an officer, director, employee, trustee, committee member or otherwise. Executive agrees to execute any
documents reasonably requested by the Company in accordance with the preceding sentence.

 

(e)
General Release; Continued Employment Terms; Eligibility for Severance Entitlements. Provided Executive signs and delivers
to the Company the general release attached as Exhibit B within twenty-one (21) days after the date Executive first receives it
from the Company (the “General Release”) and does not revoke the General Release within the seven (7) day revocation
period described therein, Executive’s employment with the Company will continue through the Termination Date at the same
salary as in effect on the Effective Date, subject to the terms of the Employment Agreements (as modified by this Agreement),
Executive will be eligible to earn the Severance Entitlements (as that term is defined in Section 1(f) below), and the Company
shall directly pay Executive’s legal fees and costs incurred in the negotiation of this Agreement and the Consulting Agreement
within 60 days of presentation of an invoice therefor, provided that such fees shall not exceed $5,000. Executive acknowledges
and agrees that Executive’s continued employment, his eligibility to earn the Severance Entitlements and the Company’s
agreement to pay up to $5,000 in legal fees and costs incurred in the negotiation of this Agreement and the Consulting Agreement
constitute full and adequate consideration for the General Release.

 

    	2 

    	 

    

 

(f)
Reaffirmation Agreement; Severance Payments; Vesting of Equity Awards. In addition to the Accrued Amounts, subject to Section
2 of this Agreement, if Executive (i) remains employed through the Termination Date and Executive’s employment terminates
pursuant to this Agreement as of the Termination Date (ii) signs, delivers and does not revoke the General Release as set forth
in Section 1(e), and (iii) signs and delivers to the Company the Reaffirmation Agreement attached as Exhibit C (the “Reaffirmation
Agreement”) no earlier than the Termination Date and no later than the second day following the Termination Date or
within twenty-one (21) days after the date Executive first receives the Reaffirmation Agreement from the Company, whichever is
later, and does not revoke the Reaffirmation Agreement within the seven (7) day revocation period described therein, Executive
shall be entitled to the following severance entitlements (collectively referred to herein as the “Severance Entitlements”):
(A) the Company will continue to pay Executive his annual base salary for 12 months following the Termination Date (payable at
the annual rate of $330,000 and paid in accordance with the Company’s normal payroll practices, with the first of such payments
being made on the first payroll date after the Reaffirmation Agreement becomes irrevocable and including any salary payments relating
to the period between the Termination Date and such first payment date), which payments shall continue to Executive’s estate
in the event of his death, (B) Executive’s unvested restricted stock unit (“RSU”) awards that are outstanding
on the Termination Date shall become fully vested as of the date the Reaffirmation Agreement becomes irrevocable (for clarity,
all of Executive’s outstanding RSUs, including any unvested RSUs that become vested pursuant to this Agreement, shall remain
subject to the terms of the governing RSU award agreements and will be settled in accordance with the terms of such award agreements
on the first business day following the six-month anniversary of the date of the Executive’s separation from service (as
that term is used in the RSU award agreements) or, if earlier, Executive’s death), (C) all of Executive’s outstanding
unvested stock options will become fully vested as of the date the Reaffirmation Agreement becomes irrevocable and all of Executive’s
stock options will remain exercisable until the earlier of (x) the one year anniversary of the date Executive ceases providing
consulting services pursuant to the Consulting Agreement and (y) the last day of the option’s full term, and otherwise in
accordance with the terms of the applicable award agreements and plan pursuant to which the stock options were granted, (D) Executive
will remain eligible to earn a prorated portion of his 2020 annual bonus (or the full 2020 annual bonus and a prorated portion
of the 2021 annual bonus if Executive remains employed through January 1, 2021) without regard to the termination of his employment
and notwithstanding the annual bonus not generally being paid to terminated employees, calculated based on Executive’s individual
goals (including transition goals agreed to by the CEO and Executive relating to the period following the Effective Date and ending
on the Termination Date), and with Company-wide goals and all other terms determined, and the bonus paid in cash, in accordance
with the terms of the Company’s annual bonus plan and otherwise as applied to other active senior executives of the Company,
and, with respect to Executive’s annual bonus for the year in which the Termination Date occurs, prorated by multiplying
such earned annual bonus by a fraction, the numerator of which is the number of days in the year in which the Termination Date
occurs through the Termination Date and the denominator of which is 365, and (E) if Executive timely elects continuation coverage
under COBRA, the Company will pay Executive’s COBRA continuation coverage premium for medical, dental and vision benefits
for Executive and his eligible dependents for 12 months following the Termination Date (or, if earlier, until the applicable COBRA
continuation period ends). Executive also acknowledges and agrees that Severance Entitlements constitute full and adequate consideration
for the Reaffirmation Agreement.

 

    	3 

    	 

    

(g)
Rights and Obligations under Offer Letter, Change in Control Agreement and Inventions and Restrictive Covenant Agreement.
The Offer Letter and the Change in Control Agreement will terminate and be of no further force or effect after the Termination
Date. Except for the payments and benefits provided for in this Agreement, Executive acknowledges and agrees that he is not entitled
to any severance payments or benefits under the Offer Letter, the Change in Control Agreement or otherwise as a result of the
termination of his employment. Executive represents that he is in compliance with, and will continue to comply with all obligations
set forth in the Inventions and Restrictive Covenant Agreement in accordance with their terms following the Termination Date,
and that nothing herein or otherwise alters in any way the terms of the Inventions and Restrictive Covenant Agreement or its survival
after the termination of Executive’s employment with the Company (except for the third sentence of Paragraph 8(a) of the
Inventions and Restrictive Covenant Agreement, which the Company hereby waives). Executive further agrees to execute and deliver
the Termination Certification referenced in the Inventions and Restrictive Covenant Agreement; provided, for the avoidance of
doubt, that notwithstanding anything to the contrary in the Termination Certification, Executive will be permitted to keep his
Company-issued laptop, monitor, docking station, mouse and iPad/tablet (subject to his ongoing obligations with respect to Company
confidential information), provided that after the Termination Date he shall not have access to the Company’s internal drives
or network.

 

(h)
Protected Rights; Defend Trade Secrets Act Notification:

 

Notwithstanding
anything to the contrary in the Inventions and Restrictive Covenant Agreement:

 

(i)
Executive is hereby notified that 18 U.S.C. § 1833(b) states as follows:

 

“An
individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a
trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly
or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law;
or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.”

 

Accordingly,
notwithstanding anything to the contrary in this Agreement or the Inventions and Restrictive Covenant Agreement, Executive understands
that he has the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney,
for the sole purpose of reporting or investigating a suspected violation of law. Executive understands that he also has the right
to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and
protected from public disclosure. Executive understands and acknowledges that nothing in this Agreement or the Inventions and
Restrictive Covenant Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade
secrets that are expressly allowed by 18 U.S.C. § 1833(b).

 

    	4 

    	 

    

(ii)
Nothing in this Agreement, the Inventions and Restrictive Covenant Agreement, the General Release or the Reaffirmation Agreement
shall prohibit or interfere with the Executive exercising protected rights, including rights under the National Labor Relations
Act, filing a charge with the Equal Employment Opportunity Commission; reporting possible violations of law to or participating
in an investigation by any federal, state or local government agency or commission such as the National Labor Relations Board,
the Department of Labor, OSHA, the Department of Justice, or the Securities and Exchange Commission. Executive does not need the
Company’s advance permission to file any such charge or report or to participate in any such investigation. Executive does,
however, waive any right to receive any monetary award or benefit resulting from such a charge, report, or investigation related
to any Executive Released Claims, except that Executive may receive and retain a monetary award from a government-administered
whistleblower award program.

 

2.
Failure to Comply with Employment Agreements or Employment Separation Terms. If (i) prior to the Termination Date, Executive
materially violates or otherwise materially breaches the terms of this Agreement or the Employment Agreements, where such breach
remains uncured fifteen days after written notification is provided to the Executive (unless such breach is unable to be cured,
in which case no fifteen day notice period shall be required), or (ii) prior to the Termination Date, Executive is terminated
for “Cause” (as defined in the Change in Control Agreement”) or resigns, or (iii) if Executive has not executed
(or revokes) the General Release or the Reaffirmation Agreement as provided for and within the time limits set forth in Sections
1(e) and 1(f) of this Agreement (any such event, a “Termination Event”), all of Executive’s unexercised
RSUs and all of Executive’s unexercised stock options (whether or not vested) will immediately be forfeited and Executive
will have no further rights with respect to such awards, Executive shall have no rights to the Severance Entitlements, and the
Company shall have no further obligations pursuant to Section 4(b). All other provisions of this Agreement, the General Release,
and the Reaffirmation Agreement (as applicable) shall survive a Termination Event. For purposes of this section, material breach
of this Agreement includes, but is not limited to the following: any failure of Executive, whether due to bad faith or negligence,
to comply with the terms of the Inventions and Restrictive Covenants Agreement.

 

3.
No Admission of Liability. The parties acknowledge and agree that any payments or benefits provided to Executive under
the terms of this Agreement do not constitute an admission by either party or any of their affiliates that they have violated
any law or legal obligation with respect to any aspect of Executive’s employment with the Company.

 

    	5 

    	 

    

4.
Non-Disparagement.

 

(a)
Subject to Section 1(h)(ii), Executive agrees that he will not, directly or indirectly, (A) make any statement, whether in commercial
or non-commercial speech, disparaging or criticizing in any way the Company or any of its subsidiaries or affiliates, or any products
or services offered by any of these entities, or (B) engage in any other conduct or make any other statement that, in each case,
should reasonably be expected to impair the goodwill or reputation of the Company; provided, however, that nothing herein or elsewhere
shall prevent Executive from making truthful disclosures or statements (x) reasonably necessary in connection with any litigation,
arbitration or mediation or (y) as required by law or by any court, arbitrator, governmental body or other person with apparent
authority to require such disclosures or statements. Without limiting the foregoing, Executive acknowledges and agrees that negative,
critical or disparaging statements regarding this Agreement or the circumstances of Executive’s termination will impair
the goodwill and reputation of the Company and shall constitute grounds for a termination pursuant to Section 2(a).

 

(b)
The Company will inform its executive officers with the title of Vice President and above and members of its board of directors,
not to, directly or indirectly, individually or in concert with others, engage in any conduct or make any statement, calculated
or likely to have the effect of undermining, disparaging or otherwise reflecting poorly upon Executive; provided, however, that
nothing herein or elsewhere shall prevent such individual from making truthful disclosures or statements (x) reasonably necessary
in connection with any litigation, arbitration or mediation or (y) as required by law or by any court, arbitrator, governmental
body or other person with apparent authority to require such disclosures or statements.

 

5.
Entire Agreement. The Company and Executive each represents and warrants that no promise or inducement has been offered
or made except as herein set forth and that the consideration stated herein is the sole consideration for this Agreement. This
Agreement (including the exhibits hereto) constitute the complete and entire agreement, and states fully all agreements, understandings,
promises and commitments between the Company and Executive relating to the subject matter hereof. This Agreement supersedes and
cancels any and all other negotiations, understandings and agreements, oral or written, respecting the subject matter hereof,
between Executive and the Company or any of its subsidiaries or other affiliates (other than the Offer Letter and the Change in
Control Agreement, each of which will remain in effect until the Termination Date, and the Inventions and Restrictive Covenant
Agreement, which shall remain in full force and effect indefinitely to the extent by its terms it survives termination of Executive’s
employment, and other than the third sentence of Paragraph 8(a) of the Inventions and Restrictive Covenant Agreement, which the
Company hereby waives); provided, for the avoidance of doubt, that in the event of conflict between this Agreement and any of
the Employment Agreements, this Agreement shall control. This Agreement may not be modified except by an instrument in writing
signed by the party against whom the enforcement of any waiver, change, modification, or discharge is sought.

 

6.
Assignability; Successors; Governing Law. This Agreement is personal to Executive and Executive may not assign, pledge,
delegate or otherwise transfer to any person or entity any of Executive’s rights, obligations or duties under this Agreement.
Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise)
to all or substantially all of the Company’s business and/or assets will assume the obligations under this Agreement and
agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would
be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company”
will include any successor to the Company’s business and/or assets, regardless of whether such party executes and delivers
any assumption agreement, or any other successor that becomes bound by the terms of this Agreement by operation of law. This Agreement
shall be governed by, construed in accordance with, and enforced pursuant to the laws of the State of California without regard
to principles of conflict of laws. Subject to the Arbitration provision below, the Superior Court of Yolo County and/or the United
States District Court for the Eastern District of California shall have exclusive jurisdiction and venue over all controversies;
provided, however, that either Party may seek equitable remedies, including injunctive relief and specific performance,
for the purpose of protecting its intellectual property rights in any court of competent jurisdiction, wherever located.

 

    	6 

    	 

    

7.
Enforceability; Arbitration.

 

(a)
Each of the covenants and agreements set forth in this Agreement are separate and independent covenants, each of which has been
separately bargained for and the parties hereto intend that the provisions of each such covenant shall be enforced to the fullest
extent permissible. Should the whole or any part or provision of any such separate covenant be held or declared invalid, such
invalidity shall not in any way affect the validity of any other such covenant or of any part or provision of the same covenant
not also held or declared invalid. If any covenant shall be found to be invalid but would be valid if some part thereof were deleted
or the period or area of application reduced, then such covenant shall apply with such minimum modification as may be necessary
to make it valid and effective. The failure of either party at any time to require performance by the other party of any provision
hereunder will in no way affect the right of that party thereafter to enforce the same, nor will it affect any other party’s
right to enforce the same, or to enforce any of the other provisions in this Agreement; nor will the waiver by either party of
the breach of any provision hereof be taken or held to be a waiver of any prior or subsequent breach of such provision or as a
waiver of the provision itself.

 

(b)
The Company and Executive each agrees that any and all disputes arising out of the terms of this Agreement, the Exhibits hereto,
any of the matters herein released, and the Inventions and Restrictive Covenant Agreement will be subject to binding confidential
arbitration. “Confidential” means the fact of a dispute, the fact of the arbitration, the details of the arbitration,
and the result shall be kept confidential by the Parties. The arbitration shall be conducted by one arbitrator, under the auspices
of JAMS and under its then-current Streamlined Arbitration Rules and Procedures (if no disputed claim or counterclaim exceeds
$250,000, not including interest or attorneys’ fees), or under its then-current Comprehensive Arbitration Rules and Procedures
(if any disputed claim or counterclaim exceeds $250,000, not including interest or attorneys’ fees). Any arbitration will
be governed by the Federal Arbitration Act (“FAA”) and conducted in a manner consistent with the JAMS Rules,
supplemented by the California Rules of Civil Procedure, to the extent permitted by the FAA. The power of the arbitrator shall
not exceed that possessed by a judge in a Superior Court in California. The arbitrator shall issue a written opinion in support
of his or her decision, stating the legal and factual basis for the decision and the reasoning leading to such decision. The arbitrator
is prohibited from awarding damages or remedies in excess of those allowed by the provisions of this Agreement. The decision and
award of the arbitrator shall be final and binding and judgment on the award so rendered may be entered in any court having jurisdiction.
The arbitration shall be held in Yolo County, California, or a mutually convenient location. The parties further agree that the
prevailing party in any arbitration will be entitled to injunctive relief in any court of competent jurisdiction to enforce the
arbitration award. This paragraph will not prevent either party from seeking provisional relief (including a temporary restraining
order or preliminary injunction) from any court having jurisdiction over the parties and the subject matter of their dispute relating
to Executive’s obligations under this Agreement and the Inventions and Restrictive Covenant Agreement. BY AGREEING TO THIS
BINDING ARBITRATION PROVISION, BOTH EXECUTIVE AND THE COMPANY GIVE UP ALL RIGHTS TO TRIAL BY JURY.

 

    	7 

    	 

    

8.
Counterparts. This Agreement may be executed in counterparts, each of which together constitute one and the same instrument.
Signatures delivered by facsimile or email PDF shall be effective for all purposes.

 

9.
Notices. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have
been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage
prepaid. In the case of Executive, mailed notices will be addressed to his at the home address which he most recently communicated
to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all
notices will be directed to the attention of the CEO or General Counsel.

 

10.
No Construction against Drafter. No provision of this Agreement or any related document will be construed against or interpreted
to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such party having
or being deemed to have structured or drafted such provision.

 

11.
Taxes. Notwithstanding anything to the contrary in this Agreement, the Company may withhold from all amounts payable under
this Agreement all federal, state, local and foreign taxes that are required to be withheld pursuant to any applicable laws and
regulations. Notwithstanding anything to the contrary in this Agreement, Executive and the Company agree that this Agreement shall
be interpreted to comply with or be exempt from Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations
and authoritative guidance promulgated thereunder to the extent applicable (collectively “Section 409A”), and
all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties
under Section 409A. However, the Company makes no representation that any or all of the payments described in this Agreement will
be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment.
Executive understands and agrees that Executive shall be solely responsible for the payment of any taxes, penalties, interest
or other expenses incurred by Executive on account of noncompliance with Section 409A and in no event will the Company, any of
its subsidiaries or other affiliates, or any of their respective directors, officers, agents, attorneys, employees, executives,
shareholders, investors, members, managers, trustees, fiduciaries, representatives, principals, accountants, insurers, successors
or assigns be liable for any additional tax, interest or penalties that may be imposed on the Executive under Section 409A or
any damages for failing to comply with Section 409A.

 

[Signatures
appear on following page]

 

    	8 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed and delivered this Employment Separation Agreement as of the day and year set
forth below.

 

	 	Marrone
    Bio Innovations, Inc.
	 	 	 
	 	By:	/s/
    Kevin Helash
	Dated:
    September 21, 2020	Name:	Kevin
    Helash
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	EXECUTIVE
    
	Dated:
    September 21, 2020	 	 
	 	/s/ James B. Boyd
	 	James B. Boyd

 

[Signature
Page to Employment Separation Agreement]

 

    	 

    	 

    

 

Exhibit
A

 

Employee
Confidential Information and Assignment of Inventions Agreement

 

    	 

    	 

    

 

Exhibit
B

 

General
Release

 

This
General Release (“Release”) is entered into as of September 21, 2020, by and between James B. Boyd (“Executive”)
and Marrone Bio Innovations, Inc. (the “Company”). Executive and the Company are sometimes collectively referred
to as the “Parties.”

 

1.
In consideration for Executive’s execution of this Release and Executive’s promises and covenants contained (a) herein
and (b) in the Employment Separation Agreement between the Company and Executive (the “Employment Separation Agreement”),
the Company agrees to provide to Executive the benefit described in Section 1(e) of the Employment Separation Agreement, subject
to the effectiveness of this Release in accordance with paragraph 4 of this Release.

 

2.
Executive hereby reaffirms his promises and covenants set forth in the Employment Separation Agreement, the terms of which Separation
Agreement are incorporated herein by reference in their entirety as though fully set forth herein, including, without limitation,
Executive’s promises and covenants set forth in paragraphs 1, 2, 4, and 7 of the Employment Separation Agreement.

 

3.
Executive, on behalf of himself, his heirs, executors, agents, representatives, and assigns (collectively, the “Releasors”)
hereby fully acquits, releases, waives and discharges the Company, its and their affiliated, related, parent or subsidiary companies,
and its and their predecessors, successors, and present and former officers, directors, committee members, representatives, attorneys,
agents or employees (the “Company Parties”) from any and all claims, obligations, liabilities, complaints,
causes of action, charges, debts, and demands of whatever kind whatsoever, in law or in equity, known or unknown, asserted or
unasserted (“Claims”), which Executive has ever had or now has against the Company Parties, including without
limitation, Claims arising out of or in any way related to Executive’s relationship with any or all of the Company Parties
and all Claims with respect to any aspect of Executive’s employment, compensation, or termination from employment by the
Company (“Executive Released Claims”). Executive Released Claims include, but are not limited to:

 

(i)
all Claims arising from Executive’s employment with the Company or the termination of that employment, including Claims
for wrongful termination or retaliation and the terms and conditions of employment;

 

(ii)
all Claims related to Executive’s compensation or benefits from the Company, including, salary, wages, overtime, meal and
rest breaks, bonuses, commissions, incentive compensation, profit sharing, retirement benefits, paid time off, vacation, sick
leave, leaves of absence, expense reimbursements, equity, severance pay, and fringe benefits;

 

(iii)
all Claims for breach of contract, breach of quasi-contract, promissory estoppel, detrimental reliance, and breach of the implied
covenant of good faith and fair dealing;

 

(iv)
all tort Claims, including Claims for fraud, defamation, slander, libel, disparagement, negligent or intentional infliction of
emotional distress, personal injury, negligence, compensatory or punitive damages, negligent or intentional misrepresentation,
and discharge in violation of public policy;

 

(v)
all federal, state, and local statutory Claims, including Claims for discrimination, harassment, retaliation, attorneys’
fees, medical expenses, experts’ fees, costs and disbursements; and

 

(vi)
any other Claims of any kind whatsoever, arising from the beginning of time until the date Executive signs this Release, in each
case whether based on contract, tort, statute, local ordinance, regulation or any comparable law, public policy or common law
in any jurisdiction.

 

    	 

    	 

    

 

By
way of example and not in limitation of the foregoing, Executive Released Claims include any Claims arising under Title VII of
the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq.; the Civil Rights Act of 1991; the Civil Rights Acts of 1866
and/or 1871, 42 U.S.C. Section 1981; the Americans with Disabilities Act, 42 U.S.C. 12101 et seq., the Age Discrimination
in Employment Act (“ADEA”), 29 U.S.C. § 621 et seq.; the Family Medical Leave Act, 29 U.S.C. § 2601 et
seq.; Executive Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. § 1001 et seq.; the federal
Worker Adjustment Retraining Notification Act (“WARN Act”), 29 U.S.C. § 2102 et seq., the California WARN
Act, California Labor Code § 1400 et seq., the California Fair Employment and Housing Act, Cal. Gov. Code §12900 et
seq., the California Labor Code and the orders of the California Industrial Welfare Commission. Executive and the Company
intend for this release to be enforced to the fullest extent permitted by law. EXECUTIVE UNDERSTANDS AND AGREES THAT THIS RELEASE
CONTAINS A GENERAL RELEASE OF ALL CLAIMS.

 

4.
Executive further unconditionally releases and forever discharges the Company Parties from any and all Claims that Executive may
have as of the date Executive signs this Release arising under the ADEA. By signing this Release, Executive acknowledges and confirms
that: (i) Executive has been advised by the Company to consult with an attorney of Executive’s choice before signing this
Release; (ii) Executive was given no fewer than twenty-one (21) days to consider the terms of this Release, although Executive
may sign it sooner if desired; (iii) Executive is providing this release in exchange for consideration in addition to that to
which Executive is already entitled; (iv) Executive has seven (7) days from the date of signing this Release to revoke this Release
by providing the Company with a written notice of revocation delivered to Linda Moore, General Counsel and Corporate Secretary,
at lmoore@marronebio.com or to the Company’s physical address at 1540 Drew Avenue, Davis, California 95618, in a manner
reasonably calculated to be received by the Company on or before the end of such seven-day period (“Revocation Period”);
(v) this Release will not become effective until the Revocation Period passes without Executive revoking the Agreement; (vi) the
release contained in this paragraph does not apply to rights and claims that may arise after the date on which Executive signs
this Release, and (vii) Executive knowingly and voluntarily accepts the terms of this Release. Executive further agrees that any
change to this Release, whether material or immaterial, will not restart the twenty-one (21) day period for Executive to consider
the terms of this Release.

 

5.
The Releasors and the Company acknowledge that they are aware of the provisions of California Civil Code, Section 1542, which
reads as follows:

 

“A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER
FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT
WITH THE DEBTOR OR RELEASED PARTY.”

 

The
Releasors hereby expressly give up all the benefits of Section 1542 and of any other similar law of this or any other jurisdiction.
The Releasors acknowledge that there may exist claims or facts in addition to or different from those which are now known or believed
by the Releasors to exist and the Releasors agree that it is their intention to fully settle and release such claims, whether
known or unknown, that may exist as of the date of this Release.

 

6.
Notwithstanding anything to the contrary set forth in paragraph 3, 4, or 5 of this Release, the Releasors do not waive, release
or discharge the Company Parties from Executive’s rights, if any, to vested benefits under the Company’s 401(k) retirement
plan or with respect to Executive’s outstanding equity awards, if any; Executive’s rights, if any, to indemnification
or advancement of expenses in accordance with the Company’s certificate of incorporation, bylaws or other corporate governance
document, or any applicable insurance policy or applicable law, including Section 2802 of the California Labor Code; any Claim
which may arise in the future from events or actions occurring after the date that Executive executes this Release; Claims for
worker’s compensation benefits; Claims for unemployment insurance benefits; any Claims that cannot be released in accordance
with applicable law; and any rights created by this Release or the Employment Separation Agreement.

 

    	 

     

    

 

7.
Executive hereby represents that Executive has not filed or commenced any proceeding against any of the Releasees based upon any
Executive Released Claims.

 

8.
Executive warrants that no promise or inducement has been offered for this Release other than as set forth herein and that this
Release is executed without reliance upon any other promises or representations, oral or written. Any modification of this Release
must be made in writing and be signed by Executive and the Company.

 

9.
If any provision of this Release or compliance by Executive or the Company with any provision of the Release constitutes a violation
of any law, or is or becomes unenforceable or void, then such provision, to the extent only that it is in violation of law, unenforceable
or void, will be deemed modified to the extent necessary so that it is no longer in violation of law, unenforceable or void, and
such provision will be enforced to the fullest extent permitted by law. If such modification is not possible, such provision,
to the extent that it is in violation of law, unenforceable or void, will be deemed severable from the remaining provisions of
this Release, which provisions will remain binding on both Executive and the Company. This Release is governed by, and construed
and interpreted in accordance with the laws of the State of California, without regard to principles of conflicts of law. This
Release, together with the Employment Separation Agreement, represents the entire understanding of the Parties with respect to
subject matter herein; no oral representations have been made or relied upon by the Parties. The Company and Executive each agrees
that any and all disputes arising out of the terms of this Agreement, any of the matters herein released, and the Inventions and
Restrictive Covenant Agreement will be subject to binding confidential arbitration. “Confidential” means the fact
of a dispute, the fact of the arbitration, the details of the arbitration, and the result shall be kept confidential by the Parties.
The arbitration shall be conducted by one arbitrator, under the auspices of JAMS and under its then-current Streamlined Arbitration
Rules and Procedures (if no disputed claim or counterclaim exceeds $250,000, not including interest or attorneys’ fees),
or under its then-current Comprehensive Arbitration Rules and Procedures (if any disputed claim or counterclaim exceeds $250,000,
not including interest or attorneys’ fees). Any arbitration will be governed by the Federal Arbitration Act (“FAA”)
and conducted in a manner consistent with the JAMS Rules, supplemented by the California Rules of Civil Procedure, to the extent
permitted by the FAA. The power of the arbitrator shall not exceed that possessed by a judge in a Superior Court in California.
The arbitrator shall issue a written opinion in support of his or her decision, stating the legal and factual basis for the decision
and the reasoning leading to such decision. The arbitrator is prohibited from awarding damages or remedies in excess of those
allowed by the provisions of this Agreement. The decision and award of the arbitrator shall be final and binding and judgment
on the award so rendered may be entered in any court having jurisdiction. The arbitration shall be held in Yolo County, California,
or a mutually convenient location. The parties further agree that the prevailing party in any arbitration will be entitled to
injunctive relief in any court of competent jurisdiction to enforce the arbitration award. This paragraph will not prevent either
party from seeking provisional relief (including a temporary restraining order or preliminary injunction) from any court having
jurisdiction over the parties and the subject matter of their dispute relating to Executive’s obligations under this Agreement
and the Inventions and Restrictive Covenant Agreement. BY AGREEING TO THIS BINDING ARBITRATION PROVISION, BOTH EXECUTIVE AND THE
COMPANY GIVE UP ALL RIGHTS TO TRIAL BY JURY.

 

10.
No action taken by the Parties hereto, or either of them, either previously or in connection with this Release, shall be deemed
or constructed to be: (a) an admission of the truth or falsity of any claims heretofore made; or (b) an acknowledgment or admission
by either party of any fault or liability whatsoever to the other party or to any third party.

 

11.
Each of the Company Parties, other than the Company, is intended to be a third party beneficiary of this Release.

 

[Signatures
appear on following page]

 

    	 

     

    

 

	EXECUTIVE’S
    ACCEPTANCE OF RELEASE
	 
	BEFORE
    SIGNING MY NAME TO THE RELEASE, I STATE THE FOLLOWING: I HAVE READ THE RELEASE, I UNDERSTAND IT AND I KNOW THAT I AM GIVING
    UP IMPORTANT RIGHTS. I HAVE OBTAINED SUFFICIENT INFORMATION TO INTELLIGENTLY EXERCISE MY OWN JUDGMENT. I HAVE BEEN ADVISED
    THAT I SHOULD CONSULT WITH AN ATTORNEY BEFORE SIGNING IT, AND I HAVE SIGNED THE RELEASE KNOWINGLY AND VOLUNTARILY.

 

	 Date
delivered to Executive: September 21, 2020
	 
	 	 
	Executed
    this 21st day of September, 2020.	 
	 	 
	/s/
    James B. Boyd	 
	James
    B. Boyd	 

 

[Signature
Page to General Release Agreement]

 

    	 

     

    

 

Exhibit
C

 

Reaffirmation
Agreement

 

This
Reaffirmation Agreement (the “Reaffirmation Agreement”) is entered into as of [●], 202[●], by and
between James B. Boyd (“Executive”) and Marrone Bio Innovations, Inc. (the “Company”). Executive
and the Company are sometimes collectively referred to as the “Parties.”

 

1.
Executive’s employment with the Company terminated on [●], 202[●] (the “Termination Date”).

 

2.
The purpose of this Reaffirmation Agreement is to effectuate the intent and agreement of the Parties as reflected in the General
Release between the Parties dated as of [●], 202[●] (the “General Release”), by advancing to the
execution date of this Reaffirmation Agreement the effective date of Executive’s general waiver and release of all Claims
against the Released Parties, as set forth in the Release Agreement.

 

3.
In consideration for Executive’s execution of this Reaffirmation Agreement and Executive’s promises and covenants
contained (a) herein and (b) in the Employment Separation Agreement between the Company and Executive (the “Employment
Separation Agreement”), the Company agrees to provide to Executive the benefit described in Section 1(f) of the Employment
Separation Agreement, subject to the effectiveness of this Release in accordance with paragraph 6 of this Release.

 

4.
Executive hereby reaffirms his promises and covenants set forth in the Employment Separation Agreement, the terms of which Separation
Agreement are incorporated herein by reference in their entirety as though fully set forth herein, including, without limitation,
Executive’s promises and covenants set forth in paragraphs 1, 2, 4, and 7 of the Employment Separation Agreement.

 

5.
Accordingly, with his signature below, Executive, on behalf of himself, his heirs, executors, agents, representatives, and assigns
(collectively, the “Releasors”), hereby specifically acknowledges and reaffirms that he the fully acquits,
releases, waives and discharges the Company, its and their affiliated, related, parent or subsidiary companies, and its and their
predecessors, successors, and present and former officers, directors, committee members, representatives, attorneys, agents or
employees (the “Company Parties”) from any and all claims, obligations, liabilities, complaints, causes of
action, charges, debts, and demands of whatever kind whatsoever, in law or in equity, known or unknown, asserted or unasserted
(“Claims”), which Executive has ever had or now has against the Company Parties, including without limitation,
Claims arising out of or in any way related to Executive’s relationship with any or all of the Company Parties and all Claims
with respect to any aspect of Executive’s employment, compensation, or termination from employment by the Company (“Executive
Released Claims”). Executive Released Claims include, but are not limited to:

 

(i)
all Claims arising from Executive’s employment with the Company or the termination of that employment, including Claims
for wrongful termination or retaliation and the terms and conditions of employment;

 

(ii)
all Claims related to Executive’s compensation or benefits from the Company, including, salary, wages, overtime, meal and
rest breaks, bonuses, commissions, incentive compensation, profit sharing, retirement benefits, paid time off, vacation, sick
leave, leaves of absence, expense reimbursements, equity, severance pay, and fringe benefits;

 

(iii)
all Claims for breach of contract, breach of quasi-contract, promissory estoppel, detrimental reliance, and breach of the implied
covenant of good faith and fair dealing;

 

    	 

     

    

 

(iv)
all tort Claims, including Claims for fraud, defamation, slander, libel, disparagement, negligent or intentional infliction of
emotional distress, personal injury, negligence, compensatory or punitive damages, negligent or intentional misrepresentation,
and discharge in violation of public policy;

 

(v)
all federal, state, and local statutory Claims, including Claims for discrimination, harassment, retaliation, attorneys’
fees, medical expenses, experts’ fees, costs and disbursements; and

 

(vi)
any other Claims of any kind whatsoever, arising from the beginning of time until the date Executive signs this Release, in each
case whether based on contract, tort, statute, local ordinance, regulation or any comparable law, public policy or common law
in any jurisdiction.

 

By
way of example and not in limitation of the foregoing, Executive Released Claims include any Claims arising under Title VII of
the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq.; the Civil Rights Act of 1991; the Civil Rights Acts of 1866
and/or 1871, 42 U.S.C. Section 1981; the Americans with Disabilities Act, 42 U.S.C. 12101 et seq., the Age Discrimination
in Employment Act (“ADEA”), 29 U.S.C. § 621 et seq.; the Family Medical Leave Act, 29 U.S.C. § 2601 et
seq.; Executive Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. § 1001 et seq.; the federal
Worker Adjustment Retraining Notification Act (“WARN Act”), 29 U.S.C. § 2102 et seq., the California WARN
Act, California Labor Code § 1400 et seq., the California Fair Employment and Housing Act, Cal. Gov. Code §12900 et
seq., the California Labor Code and the orders of the California Industrial Welfare Commission. Executive and the Company
intend for this release to be enforced to the fullest extent permitted by law. EXECUTIVE UNDERSTANDS AND AGREES THAT THIS RELEASE
CONTAINS A GENERAL RELEASE OF ALL CLAIMS.

 

Executive
understands and agrees that such waiver and release will be effective as to all Claims arising on or before the date he executes
this Reaffirmation Agreement, subject to his effectuation of this Reaffirmation Agreement in the manner set forth in the next
Section hereof. Executive further understands and agrees that he will not be entitled to the consideration provided for in Section
1(f) of the Employment Separation Agreement unless and until Executive executes this Reaffirmation Agreement and the Revocation
Period described in the next Section hereof passes without Executive revoking this Reaffirmation Agreement.

 

6.
Executive further unconditionally releases and forever discharges the Company Parties from any and all Claims that Executive may
have as of the date Executive signs this Reaffirmation Agreement arising under the ADEA. By signing this Reaffirmation Agreement,
Executive acknowledges and confirms that: (i) Executive has been advised by the Company to consult with an attorney of Executive’s
choice before signing this Reaffirmation Agreement; (ii) Executive was given no fewer than twenty-one (21) days to consider the
terms of this Reaffirmation Agreement, although Executive may sign it sooner if desired; (iii) Executive is providing the release
provided for in in this Reaffirmation Agreement is in exchange for consideration in addition to that to which Executive is already
entitled; (iv) Executive has seven (7) days from the date of signing this Reaffirmation Agreement to revoke this Reaffirmation
Agreement by providing the Company with a written notice of revocation delivered to Linda Moore, General Counsel and Corporate
Secretary, at lmoore@marronebio.com or to the Company’s physical address at 1540 Drew Avenue, Davis, California 95618, in
a manner reasonably calculated to be received by the Company on or before the end of such seven-day period (“Revocation
Period”); (v) this Reaffirmation Agreement will not become effective until the Revocation Period passes without Executive
revoking this Reaffirmation Agreement; (vi) the release contained in this Reaffirmation Agreement does not apply to rights and
claims that may arise after the date on which Executive signs this Reaffirmation Agreement, and (vii) Executive knowingly and
voluntarily accepts the terms of this Reaffirmation Agreement. Executive further agrees that any change to this Reaffirmation
Agreement or the Release Agreement, whether material or immaterial, will not restart the twenty-one (21) day period for Executive
to consider the terms of this Reaffirmation Agreement.

 

    	 

     

    

 

7.
The Releasors and the Company acknowledge that they are aware of the provisions of California Civil Code, Section 1542, which
reads as follows:

 

“A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER
FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT
WITH THE DEBTOR OR RELEASED PARTY.”

 

The
Releasors hereby expressly give up all the benefits of Section 1542 and of any other similar law of this or any other jurisdiction.
The Releasors acknowledge that there may exist claims or facts in addition to or different from those which are now known or believed
by the Releasors to exist and the Releasors agree that it is their intention to fully settle and release such claims, whether
known or unknown, that may exist as of the date of this Release.

 

8.
Notwithstanding anything to the contrary set forth in paragraph 5, 6, or 7 of this Release, the Releasors do not waive, release
or discharge the Company Parties from Executive’s rights, if any, to vested benefits under the Company’s 401(k) retirement
plan or with respect to Executive’s outstanding equity awards, if any; Executive’s rights, if any, to indemnification
or advancement of expenses in accordance with the Company’s certificate of incorporation, bylaws or other corporate governance
document, or any applicable insurance policy or applicable law, including Section 2802 of the California Labor Code; any Claim
which may arise in the future from events or actions occurring after the date that Executive executes this Reaffirmation Agreement;
Claims for worker’s compensation benefits; Claims for unemployment insurance benefits; any Claims that cannot be released
in accordance with applicable law; and any rights created by this Reaffirmation Agreement, the General Release or the Employment
Separation Agreement.

 

9.
Executive hereby represents that Executive has not filed or commenced any proceeding against any of the Releasees based upon any
Executive Released Claims.

 

10.
Executive warrants that no promise or inducement has been offered for this Reaffirmation Agreement other than as set forth herein
and that this Reaffirmation Agreement is executed without reliance upon any other promises or representations, oral or written.
Any modification of this Reaffirmation Agreement must be made in writing and be signed by Executive and the Company.

 

11.
If any provision of this Reaffirmation Agreement or compliance by Executive or the Company with any provision of this Reaffirmation
Agreement constitutes a violation of any law, or is or becomes unenforceable or void, then such provision, to the extent only
that it is in violation of law, unenforceable or void, will be deemed modified to the extent necessary so that it is no longer
in violation of law, unenforceable or void, and such provision will be enforced to the fullest extent permitted by law. If such
modification is not possible, such provision, to the extent that it is in violation of law, unenforceable or void, will be deemed
severable from the remaining provisions of this Reaffirmation Agreement, which provisions will remain binding on both Executive
and the Company. This Reaffirmation Agreement is governed by, and construed and interpreted in accordance with the laws of the
State of California, without regard to principles of conflicts of law. This Reaffirmation Agreement, together with the Employment
Separation Agreement, represents the entire understanding of the Parties with respect to subject matter herein; no oral representations
have been made or relied upon by the Parties. The Company and Executive each agrees that any and all disputes arising out of the
terms of this Reaffirmation Agreement, the Exhibits hereto, any of the matters herein released, and the Inventions and Restrictive
Covenant Agreement will be subject to binding confidential arbitration. “Confidential” means the fact of a dispute,
the fact of the arbitration, the details of the arbitration, and the result shall be kept confidential by the Parties. The arbitration
shall be conducted by one arbitrator, under the auspices of JAMS and under its then-current Streamlined Arbitration Rules and
Procedures (if no disputed claim or counterclaim exceeds $250,000, not including interest or attorneys’ fees), or under
its then-current Comprehensive Arbitration Rules and Procedures (if any disputed claim or counterclaim exceeds $250,000, not including
interest or attorneys’ fees). Any arbitration will be governed by the Federal Arbitration Act (“FAA”)
and conducted in a manner consistent with the JAMS Rules, supplemented by the California Rules of Civil Procedure, to the extent
permitted by the FAA. The power of the arbitrator shall not exceed that possessed by a judge in a Superior Court in California.
The arbitrator shall issue a written opinion in support of his or her decision, stating the legal and factual basis for the decision
and the reasoning leading to such decision. The arbitrator is prohibited from awarding damages or remedies in excess of those
allowed by the provisions of this Agreement. The decision and award of the arbitrator shall be final and binding and judgment
on the award so rendered may be entered in any court having jurisdiction. The arbitration shall be held in Yolo County, California,
or a mutually convenient location. The parties further agree that the prevailing party in any arbitration will be entitled to
injunctive relief in any court of competent jurisdiction to enforce the arbitration award. This paragraph will not prevent either
party from seeking provisional relief (including a temporary restraining order or preliminary injunction) from any court having
jurisdiction over the parties and the subject matter of their dispute relating to Executive’s obligations under this Agreement
and the Inventions and Restrictive Covenant Agreement. BY AGREEING TO THIS BINDING ARBITRATION PROVISION, BOTH EXECUTIVE AND THE
COMPANY GIVE UP ALL RIGHTS TO TRIAL BY JURY.

 

12.
No action taken by the Parties hereto, or either of them, either previously or in connection with this Reaffirmation Agreement,
shall be deemed or constructed to be: (a) an admission of the truth or falsity of any claims heretofore made; or (b) an acknowledgment
or admission by either party of any fault or liability whatsoever to the other party or to any third party.

 

13.
Each of the Company Parties, other than the Company, is intended to be a third party beneficiary of this Reaffirmation Agreement.

 

[Signatures
appear on following page]

 

    	 

     

    

  

	EXECUTIVE’S
    ACCEPTANCE OF RELEASE
	 
	BEFORE
    SIGNING MY NAME TO THE REAFFIRMATION AGREEMENT, I STATE THE FOLLOWING: I HAVE READ THE REAFFIRMATION AGREEMENT, I UNDERSTAND
    IT AND I KNOW THAT I AM GIVING UP IMPORTANT RIGHTS. I HAVE OBTAINED SUFFICIENT INFORMATION TO INTELLIGENTLY EXERCISE MY OWN
    JUDGMENT. I HAVE BEEN ADVISED THAT I SHOULD CONSULT WITH AN ATTORNEY BEFORE SIGNING THE REAFFIRMATION AGREEMENT, AND I HAVE
    SIGNED IT KNOWINGLY AND VOLUNTARILY.

 

	 Date
delivered to Executive: [●], 202[●].
	 
	 	 
	Executed
    this ___________ day of [●], 202[●].	 
	 	 
	 	 
	James
B. Boyd
	 

 

[Signature
Page to Reaffirmation Agreement]

 

    	 

     

    

 

Exhibit
D

 

Consulting
AgreementExhibit
10.2

 

CERTAIN
IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS 

EXHIBIT
BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE 

COMPETITIVELY
HARMFUL IF PUBLICLY DISCLOSED. SUCH PORTIONS ARE 

MARKED
AS INDICATED WITH BRACKETS (“[***]”) BELOW

 

MARRONE
BIO INNOVATIONS, INC.

 

CONSULTING
AGREEMENT

 

This
Consulting Agreement (“Agreement”) is made and entered into as of the 21 day of September 2020 (“Effective
Date”) by and between Marrone Bio Innovations, Inc., a Delaware corporation with its principal place of business located
at 1540 Drew Avenue, Davis, CA 95618) (“MBI”), and James B. Boyd, (“Consultant”). MBI and
Consultant are sometimes referred to herein individually as a “Party” or collectively as “the Parties”.
For the Parties’ mutual benefit, following Consultant’s termination of employment with MBI pursuant to that certain
Employment Separation Agreement, effective as of September 21, 2020, by and between Consultant and MBI (such agreement, including
the exhibits thereto, the “Separation Agreement”), MBI desires to engage the services of Consultant as an independent
contractor, and Consultant desires to provide consulting services as an independent contractor, on terms set forth more fully
below.

 

In
consideration of the mutual promises contained herein, the Parties agree as follows:

 

1. SERVICES
AND COMPENSATION

 

(a) Services.
Consultant agrees to perform for MBI the services as described in Schedule 1 incorporated herein by reference and such
other services as may be requested by MBI from time to time (the “Services”). The Parties may delete, add
or substitute Services, extend the Term of this Agreement (defined below in Section 9(a)) or alter the terms of
compensation by amending Schedule 1, provided that such amendment must be signed by an authorized representative of
each Party and must indicate whether it is to replace or alter the then existing Schedule 1.

 

(b) Compensation.
MBI agrees to pay Consultant the compensation set forth in Schedule 1 for the performance of the Services. Such compensation
shall be payable on the schedule set forth in Schedule 1.

 

(c) MBI
Obligations. The obligations of MBI related to performance of the Services are also set forth in Schedule 1.

 

(d) Authorization
by MBI Required. Consultant is authorized to perform the Services under this Agreement only upon the request or at the direction
of an Officer of MBI.

 

    	1

     

    

 

2. CONFIDENTIALITY

 

(a) Definition.
“Confidential Information” means any MBI proprietary information, technical data, Trade Secrets or know-how,
including, but not limited to, research, product plans, products, services, customers, customer lists, markets, software, developments,
inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances
or other business information disclosed by MBI to Consultant either directly or indirectly in writing, orally, or by drawings
or inspection of parts or equipment. “Trade Secrets” means information that derives independent economic value,
actual or potential, from not being generally known to the public or other persons who can obtain economic value from its disclosure
or use, and is the subject of efforts that are reasonable under the circumstances to maintain its secrecy.

 

(b) Obligation
of Confidentiality. Consultant shall not, during or subsequent to the Term of this Agreement, use MBI’s Confidential
Information for any purpose whatsoever other than the performance of Services on behalf of MBI or disclose MBI’s Confidential
Information to any third party, and it is understood that such Confidential Information shall remain the sole property of MBI.
Consultant further agrees to take all reasonable precautions to prevent any unauthorized disclosure of such Confidential Information
including, but not limited to, having each employee of Consultant, if any, with access to any Confidential Information, execute
a nondisclosure agreement containing provisions in MBI’s favor substantially similar to Sections 2 (“Confidentiality”),
3 (“Ownership and Licenses”) and 4 (“Warranties of Originality and Noninfringement”) of
this Agreement.

 

(c) Exceptions
to Confidentiality Obligation. Confidential Information does not include information which (i) is known to Consultant (except
through Consultant’s prior employment with MBI) at the time of disclosure to Consultant by MBI as evidenced by written records
of Consultant, (ii) has become publicly known and made generally available through no wrongful act of Consultant, or (ii) has
been rightfully received by Consultant from a third party who is not bound to treat the information as confidential on behalf
of MBI and who is authorized to make such disclosure. Nothing in this Agreement shall prevent Consultant from disclosing Confidential
Information to the extent Consultant is legally compelled to do so by any court or governmental investigative, judicial, or regulatory
agency pursuant to proceedings over which such court or agency has jurisdiction; provided, however, that prior to any such disclosure,
Consultant shall: (a) assert the confidential nature of the Confidential Information to the court or agency; (b) immediately notify
MBI, in writing of the court’s or agency’s order or request to disclose; and (c) cooperate fully with MBI, at MBI’s
request, in protecting against any such disclosure and/or obtaining a protective order narrowing the scope of the compelled disclosure
and protecting the confidentiality of the Confidential Information.

 

(d) Prohibition
Against Disclosing Relationship. Without MBI’s prior written approval, Consultant shall not directly or indirectly disclose
to anyone the existence of this Agreement or the fact that Consultant is providing Services to MBI, except (i) as may be required
by law and (ii) to its attorneys, accountants, and other professional advisors.

 

    	2

     

    

 

(e) Prohibition
Against Improper Use of Third-Party Information. Consultant agrees that Consultant will not, during the Term of this Agreement
or thereafter, improperly use in connection with the Services or disclose to MBI any proprietary information or trade secrets
of any former or current employer or other person or entity with which Consultant has an agreement or duty to keep in confidence
information acquired by Consultant in confidence, if any, and that Consultant shall not bring onto the premises of MBI any confidential
or non-public document or proprietary information belonging to such employer, person or entity unless consented to in writing
by such employer, person or entity.

 

(f) Third-Party
Confidential Information Disclosed by MBI. Consultant recognizes that MBI has received and in the future will receive from
third parties their confidential or proprietary information subject to a duty on MBI’s part to maintain the confidentiality
of such information and to use it only for certain limited purposes. Consultant agrees that Consultant owes MBI and such third
parties, during the Term of this Agreement and thereafter, a duty to hold all such confidential or proprietary information in
the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in performing
the Services for MBI and in accordance with Consultant’s confidentiality obligations.

 

(g) Return
of Confidential Information and other Documents. Upon the termination of this Agreement, or upon MBI’s earlier request,
Consultant shall deliver to MBI all of MBI’s property and Confidential Information in tangible form that Consultant may
have in Consultant’s possession or control.

 

(h) Defend
Trade Secrets Act. Notwithstanding anything to the contrary in this Agreement, Consultant is hereby notified that 18
U.S.C. § 1833(b) states as follows:

 

“An
individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a
trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly
or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law;
or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.”

 

Accordingly,
notwithstanding anything to the contrary in this Agreement, Consultant understands that it has the right to disclose in confidence
trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating
a suspected violation of law. Consultant understands that it also has the right to disclose trade secrets in a document filed
in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. Consultant understands
and acknowledges that nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for
disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b).

 

    	3

     

    

 

3. OWNERSHIP
AND LICENSES

 

(a) Ownership
by MBI. Consultant agrees that all inventions and discoveries (including, but not limited to, concepts, ideas, processes,
programs, algorithms, methods, formulae, compositions, techniques, articles, and machines, as well as improvements or know-how)
and all original works of authorship, whether or not patentable, copyrightable or protectable as Trade Secrets, conceived or made
by Consultant, alone or with others, that result from Services provided by Consultant under this Agreement (collectively “Work
Product”), are the sole and exclusive property of MBI. For avoidance of doubt, Work Product does not include
Pre-Existing Material, defined in Section 3(b). Consultant hereby irrevocably assigns to MBI all of its worldwide right,
title and interest in and to the Work Product, including all intellectual property rights and moral rights. Consultant will ensure
that each of its employees who provide Services, if any, has entered into a written agreement with Consultant that appropriately
assigns, either directly to MBI or to Consultant who will then transfer these rights to MBI, any and all rights and interests
in any Work Product created in connection with this Agreement. Consultant is prohibited from using any equipment, supplies, or
Confidential Information of MBI when doing work for other entities or persons. Any inventions, discoveries, original works of
authorship, and other work done by Consultant in violation of the preceding sentence shall be considered Work Product and shall
be the sole and exclusive property of MBI; and Consultant’s assignment to MBI applies to such Work Product.

 

Consultant
irrevocably agrees not to assert against MBI or its successors, assigns, or licensees any claim of any intellectual property rights
or moral rights of Consultant relating to the Work Product. Consultant will ensure that each of its employees who provide Services,
if any, has entered into a written agreement with Consultant that appropriately waives any and all claims relating to any Work
Product created in connection with this Agreement.

 

(b) Pre-Existing
Materials. Consultant agrees that if in the course of performing the Services, Consultant incorporates into any deliverable
provided to MBI, any invention, original work of authorship, improvement, development, concept, discovery, or other proprietary
information owned by Consultant or in which Consultant has a right or license (“Pre-Existing Material”), (i)
Consultant shall inform MBI in writing before incorporating such Pre-Existing Material into any such deliverable and shall provide
substantiation of its assertion that such Pre-Existing Material is not, in fact, Work Product; and (ii) MBI is hereby granted
and shall have a nonexclusive, royalty-free, perpetual, irrevocable, worldwide license to reproduce, make derivative works based
upon, modify, perform, display, use, make, have made, sell, distribute, and import such Pre-Existing Material as part of or in
connection with such deliverable. Consultant is prohibited from incorporating any third-party materials (including, but not limited
to, open source software and Creative Commons documents and materials), intellectual property, or proprietary information into
any deliverable without MBI’s prior written approval of such incorporation.

 

(c) Future
Assurances. Consultant agrees to assist MBI, or its designee, at MBI’s expense, in every proper way to secure MBI’s
rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights in any and all countries,
including the disclosure to MBI of all pertinent information and data, the execution of all applications, specifications, oaths,
assignments and all other instruments which MBI shall deem necessary in order to apply for and obtain such rights and in order
to assign and convey to MBI, its successors, assigns and nominees the sole and exclusive rights, title and interest in and to
such Work Product, and any copyrights, patents, mask work rights or other intellectual property rights. Consultant further agrees
that Consultant’s obligation to execute or cause to be executed, when it is in Consultant’s power to do so, any such
instrument or papers shall continue after the expiration or termination of this Agreement.

 

    	4

     

    

 

(d) Power
of Attorney. Consultant agrees that if MBI is unable because of Consultant’s unavailability, dissolution, incapacity,
or for any other reason, to secure a signature by or on behalf of Consultant to apply for or to pursue any application for any
United States or foreign patents or mask work or copyright registrations covering the Work Product assigned to MBI above, then
Consultant hereby irrevocably designates and appoints MBI and its duly authorized officers and agents as Consultant’s agent
and attorney in fact, to act for and on Consultant’s behalf and stead to execute and file any such applications and to do
all other lawfully permitted acts to further the prosecution and issuance of patents, copyright and mask work registrations with
the same legal force and effect as if executed by Consultant. This appointment is coupled with an interest (which means that it
shall remain in effect even after Consultant dissolves or becomes incapacitated or dies).

 

4. WARRANTIES
OF ORIGINALITY AND NONINFRINGEMENT

 

(a) Consultant’s
Warranties. Consultant represents and warrants that all Work Product and Services provided will be original with Consultant
and will not include any third-party Trade Secrets that Consultant has unlawfully misappropriated, that the Pre-Existing Material
will not infringe upon any third-party intellectual property rights or include any third-party Trade Secrets that Consultant has
unlawfully misappropriated, and that the use by MBI or its customers, representatives, distributors or dealers will not infringe
any patent, copyright, trade secret or other intellectual property right of any third party. Consultant additionally warrants
that the Services will be performed in a professional and workmanlike manner, in conformance with the standards for comparable
services in the industry, and in compliance with any specifications or other requirements of this Agreement and Schedule 1.

 

(b) Compliance
with Laws. Consultant warrants that, in providing the Services, it will comply with all applicable federal, state, and local
laws and regulations (including, but not limited to, United States Department of Commerce and other United States export controls;
Immigration Reform and Control Act of 1986; applicable wage and hour laws; the Equal Opportunity Clause stated in 41 CFR 60-1.4(a);
Executive Order 11246 - Equal Employment Opportunity (as amended); requirements for getting a business license).

 

5. INDEMNIFICATION
BY CONSULTANT

 

Consultant
shall indemnify and hold MBI harmless against any liability, loss, cost, damage, claims, demands or expenses (including reasonable
attorney’s fees) of MBI or its customers, representatives, distributors or dealers arising out of (i) any infringement or
misappropriation or claim of infringement or misappropriation with respect to any Work Product, Pre-Existing Material, or Services
provided by Consultant; (ii) any bodily injury, death, or damage to tangible property caused by the Services or the negligence,
willful misconduct, misrepresentation, or omissions when there is a duty to act, of Consultant or of any person for whose actions
Consultant is legally liable; (iii) any violation or claimed violation of a third party’s rights resulting from Consultant’s
use of any third-party materials without permission from the third party; or (iv) any claim by a governmental entity or other
third party as a result of Consultant’s violation of any law or government regulation.

 

    	5

     

    

 

6. RECORDS
AND REPORTS

 

Consultant
agrees that it will from time to time during the Term of this Agreement keep MBI advised as to Consultant’s progress in
performing the Services and that Consultant will, as requested by MBI, prepare written reports in a form reasonably requested
by MBI. It is understood that the time required in the preparation of such written reports shall be considered time devoted to
the performance of Consultant’s Services.

 

7. NO
CONFLICTING OBLIGATIONS

 

Consultant
certifies that Consultant has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement,
or that would adversely affect Consultant’s performance, and Consultant agrees that Consultant shall not enter into any
such conflicting Agreement during the Term of this Agreement.

 

8. INSURANCE

 

During
the Term and for the period stated below, Consultant shall maintain, at its own expense, the following insurance coverage: Automobile
Liability Insurance, including coverage for all owned, leased, non-owned, and hired vehicular equipment, with minimum coverage
of Five Hundred Thousand Dollars ($500,000) per accident for bodily injury and property damage liability combined. The required
insurance shall either be maintained for four (4) years after completion of the Services or provide coverage for claims made up
to four (4) years after completion of the Services.

 

9. TERM
AND TERMINATION

 

(a) Term.
The term of Consultant’s service as a consultant to MBI pursuant to this Agreement will commence on the day immediately
following the Termination Date (as defined in the Separation Agreement, the “Commencement Date”), and will
continue for a term of one year thereafter, unless terminated earlier as provided below or extended by mutual agreement of MBI
and the Consultant (the “Term”).

 

(b) Termination
by MBI. MBI may terminate this Agreement upon giving five (5) days prior written notice to Consultant. Any such notice of
termination shall be addressed to Consultant as stated in Section 13(b) (“Notices”) below. MBI may terminate
this Agreement immediately upon notice if Consultant refuses to or is unable to perform the Services or is in breach of any material
provision of this Agreement or the Separation Agreement.

 

    	6

     

    

 

(c) Obligations
Upon Termination and Survival. Upon such termination all rights and duties of the Parties toward each other shall cease except:

 

(i) if
MBI terminates this Agreement within the one-year period following the Commencement Date for any reason other than due to Consultant’s
(A) refusal or inability to perform the Services, or (B) breach of any material provision of this Agreement or the Separation
Agreement, any unvested restricted stock units granted to Consultant in accordance with Schedule I will immediately vest; and

 

(ii) The
following Sections shall survive termination of this Agreement: 2 (“Confidentiality”), 3 (“Ownership and Licenses”).
4 (“Warranties of Originality and Noninfringement”), 5 (“Indemnification by Consultant”); 8 (“Insurance”),
9(c) (“Obligations Upon Termination and Survival”), 10 (“Assignment”), 11 (“Independent Contractor”),
12 (“Arbitration and Equitable Relief”), and 13 (“Miscellaneous”).

 

10. ASSIGNMENT

 

Neither
this Agreement nor any right or interest herein may be assigned or transferred by Consultant without the express written consent
of MBI. Any such attempted assignment shall be null and void.

 

11. INDEPENDENT
CONTRACTOR

 

(a) Independent
Contractor Status. Consultant, including any employee of Consultant, will at all times during the performance of the Services
be considered an independent contractor. The Services performed are outside the usual course of MBI’s business. Consultant
represents and warrants that Consultant is customarily engaged in an independently established trade, occupation, or business
of the same nature as the Services performed. Nothing in this Agreement shall in any way be construed to constitute Consultant
as an agent, employee or representative of MBI. This Agreement should not be construed as creating an employment relationship,
agency, partnership, joint venture or any other form of association for tax purposes or otherwise between the Parties.. Neither
Party will have the right to enter into any contracts or binding commitments in the name of the other Party or on such other Party’s
behalf. Unless otherwise stated in this Agreement, Consultant shall furnish, at its own expense, the materials, equipment, supplies,
and other resources necessary to perform the Services. MBI shall furnish to Consultant for performance of the Services the equipment,
materials and data set forth in Schedule 2. The cost to Consultant, if any, to be paid to MBI for such items is set forth
in Schedule 2. Upon the earlier of completion of the Services or termination of this Agreement, Consultant shall, within
a reasonable time, return to MBI the items furnished by MBI.

 

    	7

     

    

 

(b) Taxes.
When required, MBI will issue to Consultant and file with the Internal Revenue Service Form 1099-MISC for payments made to Consultant.
Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant
to this Agreement, and Consultant acknowledges the obligation to pay, and agrees to pay, all self-employment and other taxes,
and understands that MBI is not responsible for state unemployment insurance or workers’ compensation premiums on Consultant’s
account. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by
Consultant pursuant to this Agreement. Consultant, on behalf of Consultant and Consultant’s successors, assigns, and heirs,
agrees to defend, indemnify and hold MBI, including MBI’s employees, officers, directors, agents, subsidiaries and affiliates,
harmless from and against any damage, claim, losses, fee, assessment, interest charge or penalty incurred by or charged to MBI
as a result of any claim, cause of action or assessment by any government agency for any nonpayment or late payment by Consultant
of any tax or contribution based on compensation paid hereunder to Consultant or because MBI did not withhold any taxes from compensation
paid hereunder.

 

(c) No
Employee Benefits. Consultant acknowledges that neither Consultant nor any of its employees are entitled to any employee benefits
of MBI, including but not limited to, disability or unemployment insurance, workers’ compensation, medical or life insurance,
sick leave, compensation time, overtime, retirement or holiday benefits, vacation time, profit sharing, bonuses, or any other
employment benefit nor will MBI make deductions from any amounts payable to Consultant for taxes or insurance. All benefits, including
workers’ compensation benefits, if applicable, shall be the sole responsibility of Consultant. Consultant agrees to provide
workers’ compensation insurance for Consultant employees and agents. If Consultant is reclassified by a state or federal
agency or court as an employee of MBI for tax or other purposes, Consultant will become a non-benefit employee and will receive
no benefits from MBI, except those mandated by state or federal law, even if by the terms of the benefit plans or programs of
MBI in effect at the time of such reclassification Consultant would otherwise be eligible for such benefits.

 

12. ARBITRATION
AND EQUITABLE RELIEF

 

(a) Arbitration.
Except as provided in Section 12(b) (“Equitable Relief”) below, all disputes, claims, and controversies between
the Parties arising out of or related to this Agreement or the breach of this Agreement shall be settled by confidential arbitration.
“Confidential” means the fact of a dispute, the fact of the arbitration, the details of the arbitration, and the result
shall be kept confidential by the Parties. The arbitration shall be conducted by one arbitrator, under the auspices of JAMS and
under its then-current Streamlined Arbitration Rules and Procedures (if no disputed claim or counterclaim exceeds $250,000, not
including interest or attorneys’ fees), or under its then-current Comprehensive Arbitration Rules and Procedures (if any
disputed claim or counterclaim exceeds $250,000, not including interest or attorneys’ fees). Any arbitration will be governed
by the Federal Arbitration Act (“FAA”) and conducted in a manner consistent with the JAMS Rules, supplemented
by the California Rules of Civil Procedure, to the extent permitted by the FAA. The power of the arbitrator shall not exceed that
possessed by a judge in a Superior Court in California. The arbitrator shall issue a written opinion in support of his or her
decision, stating the legal and factual basis for the decision and the reasoning leading to such decision. The arbitrator is prohibited
from awarding damages or remedies in excess of those allowed by the provisions of this Agreement. The decision and award of the
arbitrator shall be final and binding and judgment on the award so rendered may be entered in any court having jurisdiction. The
arbitration shall be held in Yolo County, California, or a mutually convenient location. The Parties will equally share the arbitrator’s
fee and the JAMS administrative fee, but each Party shall bear its own costs and expenses, including attorney’s fees, witness
fees, travel expenses, and preparation costs. This section will not prevent either Party from seeking provisional relief (including
a temporary restraining order or preliminary injunction) from any court having jurisdiction over the Parties and the subject matter
of their dispute. BY AGREEING TO THIS BINDING ARBITRATION PROVISION, BOTH CONSULTANT AND MBI GIVE UP ALL RIGHTS TO TRIAL BY JURY.

 

    	8

     

    

 

(b) Equitable
Relief. Consultant agrees that it would be impossible or inadequate to measure and calculate MBI’s damages from any
breach of the covenants set forth in Sections 2 (“Confidentiality”) or 3 (“Ownership and Licenses”) herein.
Accordingly, Consultant agrees that if Consultant breaches Sections 2 or 3, MBI will have available, in addition to any other
right or remedy available at law or in equity, the right to obtain from any court of competent jurisdiction an injunction restraining
such breach or threatened breach and compelling specific performance of any such provision. Consultant further agrees that no
bond or other security shall be required in obtaining such equitable relief.

 

(c) Limitation
of Liability. MBI SHALL NOT BE LIABLE FOR ANY CONSEQUENTIAL, INCIDENTAL, INDIRECT, OR SPECIAL DAMAGES INCURRED, EVEN IF ADVISED
IN ADVANCE OF THE POSSIBILITY OF SUCH DAMAGES. MBI’S LIABILITY WITH RESPECT TO THIS AGREEMENT OR ANY CLAIM RELATED TO THE
SERVICES (WHETHER IN CONTRACT, TORT OR OTHERWISE) IS LIMITED TO AN AMOUNT EQUAL TO THE AMOUNTS PAID OR PAYABLE BY MBI UNDER THIS
AGREEMENT. THE FOREGOING SHALL CONSTITUTE CONSULTANT’S EXCLUSIVE REMEDY.

 

13. MISCELLANEOUS

 

(a) Entire
Agreement; Order of Precedence; and Amendment. This Agreement, including the Schedules attached, is intended as the final,
complete and exclusive statement of the terms of the agreement between the Parties, and supersedes all prior understandings, writings,
proposals, representations or communications, oral or written, relating to the subject matter hereof (other than the Inventions
and Restrictive Covenant Agreement dated [● DATE] between the Parties , which remains in full force and effect to the extent
by its terms survives termination of Consultant’s employment, and other than the third sentence of Paragraph 8(a) of the
Inventions and Restrictive Covenant Agreement, which the Company hereby waives). In the event of any conflict between the front
part of this Agreement (i.e., Sections 1 through 13) and Schedule 1, the provisions of Schedule 1 will prevail.
This Agreement may not be modified except in a writing executed by both Parties. For the avoidance of doubt, nothing in this Agreements
alters in any way the Parties’ respective rights and obligations under the Separation Agreement.

 

    	9

     

    

 

(b) Notices.
Notices shall be given in writing to the address shown at the beginning of this Agreement or under the signature block below,
or to such other address as either Party may substitute by written notice to the other. Any notice involving breach or termination
shall be personally delivered or sent by recognized overnight courier (such as Federal Express or DHL) or by certified mail, postage
pre-paid and return receipt requested. All other notices may additionally be sent by fax or e-mail with a confirmation of transmission
by the transmitting machine. All notices shall be deemed to have been given and received on the earlier of actual delivery (except
that faxes and e-mails sent on a non-business day or after business hours, according to the recipient’s business calendar,
will be deemed received on the next business day) or three (3) days from the date of postmark.

 

(c) Waiver;
No Election of Remedies. Failure of either Party to enforce compliance with any provision of this Agreement shall not constitute
a waiver of such provision unless accompanied by a clear written and signed statement that such provision is waived. A waiver
of any default or of any of the terms and conditions of this Agreement shall not be deemed to be a continuing waiver or a waiver
of any other default or of any other term or condition, but shall apply solely to the instance to which such waiver is directed.
The termination of this Agreement or the exercise of any right or remedy provided in this Agreement shall be without prejudice
to the right to exercise any other right or remedy provided or by law or equity.

 

(d) Severability.
In the event any provision of this Agreement is found to be invalid, illegal or unenforceable, a modified provision shall be substituted
which carries out as nearly as possible the original intent of the Parties, and the validity, legality and enforceability of the
remaining provisions shall not in any way be affected or impaired thereby. If no such substitution can be made, such invalid,
illegal or unenforceable provision shall be deleted, and the remaining provisions shall not in any way be affected or impaired
thereby.

 

(e) Governing
Law and Venue. This Agreement shall be construed in accordance with, and all disputes shall be governed by, the laws of the
State of California, as applied to contracts made and to be performed in California, without applying conflict of laws rules.
Subject to the Arbitration provision above, the Superior Court of Yolo County and/or the United States District Court for the
Eastern District of California shall have exclusive jurisdiction and venue over all controversies; provided, however, that
either Party may seek equitable remedies, including injunctive relief and specific performance, for the purpose of protecting
its intellectual property rights in any court of competent jurisdiction, wherever located.

 

(f) Headings.
Headings in this Agreement are for the purpose of convenience only, and are not intended to be used in its construction or interpretation.

 

(g) Counterparts.
This Agreement may be executed in two counterparts with the same effect as if both Parties had signed the same document. All counterparts
will be construed together and will constitute one agreement. A facsimile or image file (such as pdf or tiff) copy or photocopy
of this Agreement, including the signature pages, shall be deemed to be an original.

 

(h) Interpretation.
Each provision of this Agreement shall be fairly interpreted and construed in accordance with its terms and without any strict
interpretation or construction in favor of or against either Party.

 

    	10

     

    

 

The
Parties have executed this Agreement on the date(s) shown below, to be effective as of the Effective Date first above written.

 

	“Consultant”	 	“MBI”
	 	 	 	 
	 	 	MARRONE
    BIO INNOVATIONS, INC.
	 	 	 	 
	/s/
    James B. Boyd	 	By:	/s/
    Linda V. Moore
	Signature	 	 	 
	James
    B. Boyd	 	Name:	Linda
    V. Moore
	(Print
    Name)	 	 	 
	 	 	Title:	E.V.P.
    and General Counsel
	 	 	 	 
	Date:
    September 21, 2020	 	Date:	September
    21, 2020

 

Attachments

 

Schedule
1 Services, Compensation and Related Obligations

Schedule
2 Equipment and Materials to be Furnished

 

    	11

     

    

 

SCHEDULE
1

 

SERVICES,
COMPENSATION AND RELATED OBLIGATIONS

 

Contacts.

 

Consultant:

Name:
James B. Boyd

Title:
Consultant

 

MBI’s
principal contact:

Name:
Kevin Helash

Title:
CEO

Tel.
#: [***]

Fax
#:[***]

e-mail:
[***]

 

Services.

 

Consultant
will provide the following services with regard to the creation of an entity dedicated to eradication of invasive species:

 

[***]

 

It
is anticipated that the level of services Consultant will provide pursuant to this Agreement will substantially differ from and
will not exceed 20% of the average level of services Consultant provided to MBI as an employee over the 36-month period immediately
preceding the Effective Date.

 

Compensation.

 

For
all Services described above, MBI shall pay Consultant as follows:

 

200,000
restricted stock units, which will be granted as soon as practical after the Effective Date and, except as otherwise provided
in Section 9(c)(i) of the Agreement, which will vest in equal monthly installments over 12 months from the Commencement Date (as
that term is defined in Section 9(a) of the Agreement), subject to Consultant’s compliance with the terms of the Agreement
and the Separation Agreement. The restricted stock units that vest will be settled (by issuance of shares of MBI common stock)
upon, or as soon as practicable (but not more than 30 days) following, the date the restricted stock units vest. Vesting of these
restricted stock units shall accelerate in the event of Consultant’s death.

 

    	1

     

    

 

SCHEDULE
2

 

EQUIPMENT
AND MATERIALS TO BE FURNISHED

 

By
MBI:

 

Laptop,
monitor mouse, docking station

 

By
Consultant:

 

N/A

 

Cost
to Consultant for the Equipment and Materials Provided by MBI:

 

N/A

 

Items
to be Returned (in addition to all of MBI’s property and Confidential Information in tangible form):None

 

    	1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]